1. Home
  2. AGX vs TVTX Comparison

AGX vs TVTX Comparison

Compare AGX & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

SELL

Current Price

$348.80

Market Cap

5.6B

ML Signal

SELL

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$50.05

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
TVTX
Founded
1961
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.3B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
AGX
TVTX
Price
$348.80
$50.05
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
★ $570.50
$75.21
AVG Volume (30 Days)
353.9K
★ 1.6M
Earning Date
09-02-2026
10-29-2026
Dividend Yield
★ 0.54%
N/A
EPS Growth
58.37
★ 92.89
EPS
★ 7.01
N/A
Revenue
★ $944,606,000.00
N/A
Revenue This Year
$48.32
$47.65
Revenue Next Year
$20.43
$49.39
P/E Ratio
$52.32
★ N/A
Revenue Growth
★ 8.06
N/A
52 Week Low
$257.62
$22.59
52 Week High
$805.75
$68.73

Technical Indicators

Market Signals
Indicator
AGX
TVTX
Relative Strength Index (RSI) 33.95 26.84
Support Level $333.39 $41.75
Resistance Level $447.21 $59.93
Average True Range (ATR) 17.71 2.32
MACD 1.18 -0.49
Stochastic Oscillator 5.99 1.66

Price Performance

Historical Comparison
AGX
TVTX

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Teledata, out of which Power Services derives the majority of revenue.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: